DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Reset all filters
01 1Dr. Reddy's Laboratories Limited
02 2Azico Biophore India Private Limited
03 1Cipla Ltd.
04 2HETERO DRUGS LIMITED
05 2Maithri Laboratories Private Limited
Reset all filters
01 1ELIGLUSTAT TARTRATE
02 3Eliglustat Tartrate
03 1Eliglustat Tartrate (Amorphous)
04 1Eliglustat Tartrate (Premix)
05 1Eliglustat Tartrate Premix
06 1Eliglustat tartrate
Reset all filters
01 8India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 71796-009
Start Marketing Date : 2017-03-13
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 69575-4031
Start Marketing Date : 2021-12-16
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 69575-4046
Start Marketing Date : 2021-12-16
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53104-7735
Start Marketing Date : 2018-03-30
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65977-0151
Start Marketing Date : 2014-08-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65977-0155
Start Marketing Date : 2014-08-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 71666-002
Start Marketing Date : 2018-03-28
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 71666-004
Start Marketing Date : 2018-03-27
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
52
PharmaCompass offers a list of Eliglustat API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Eliglustat manufacturer or Eliglustat supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Eliglustat manufacturer or Eliglustat supplier.
PharmaCompass also assists you with knowing the Eliglustat API Price utilized in the formulation of products. Eliglustat API Price is not always fixed or binding as the Eliglustat Price is obtained through a variety of data sources. The Eliglustat Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Eliglustat manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Eliglustat, including repackagers and relabelers. The FDA regulates Eliglustat manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Eliglustat API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Eliglustat manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Eliglustat supplier is an individual or a company that provides Eliglustat active pharmaceutical ingredient (API) or Eliglustat finished formulations upon request. The Eliglustat suppliers may include Eliglustat API manufacturers, exporters, distributors and traders.
click here to find a list of Eliglustat suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Eliglustat as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Eliglustat API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Eliglustat as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Eliglustat and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Eliglustat NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Eliglustat suppliers with NDC on PharmaCompass.
We have 5 companies offering Eliglustat
Get in contact with the supplier of your choice: